Murray Discusses ACA Marketplace Shifts and Nonnetwork Plans
ACA marketplace changes threaten premium tax credits, pushing enrollees toward high‑deductible bronze plans that may cost thousands more in expenses.
Margaret Murray Critiques Republicans on Medicaid Stance
Margaret Murray critiques Republicans on Medicaid stance, calling the overhaul's provisions, including work requirements and redetermination cycles, deeply conc
AI Tool Forecasts Diabetes Complications
New AI tool forecasts diabetes complications in patients, helping prevent heart disease and kidney disease risks.
FDA approves new drug for rare bone disease
The FDA approves Pasatru, a breakthrough drug for fibrodysplasia ossificans progressiva (FOP), a rare bone disease affecting 900 people worldwide.
Sparsentan Access Guidance for Kidney Disease Patients
Sparsentan access guidance for kidney disease patients with evidence-based coverage criteria and clinical judgment.
California’s generic insulin struggles to gain traction
California’s generic insulin program, CalRx, offers affordable insulin at $55 but faces slow adoption despite lower costs. Learn why.
Hospitals Now Require Payment Upfront
Hospitals now require payment upfront, adding a new financial responsibility for patients with hospital prepayment requirements.
Trump Team Puts Medicaid at Risk
Trump team puts Medicaid at risk for low-income individuals, potentially changing health coverage next year.
Medicare Advantage firm settles billing case for $342M
A Medicare Advantage insurer pays $342M to settle overbilling allegations, signaling stricter regulatory oversight for the program.
Opioid funds spark Capitol budget fight
Washington D.C. faces backlash for redirecting opioid settlement funds to Medicaid, sparking a budget battle over addiction treatment priorities.